Zhonghuang Li

596 total citations
32 papers, 508 citations indexed

About

Zhonghuang Li is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Zhonghuang Li has authored 32 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 9 papers in Organic Chemistry and 7 papers in Oncology. Recurrent topics in Zhonghuang Li's work include Cancer therapeutics and mechanisms (10 papers), Computational Drug Discovery Methods (6 papers) and Quinazolinone synthesis and applications (6 papers). Zhonghuang Li is often cited by papers focused on Cancer therapeutics and mechanisms (10 papers), Computational Drug Discovery Methods (6 papers) and Quinazolinone synthesis and applications (6 papers). Zhonghuang Li collaborates with scholars based in China and United States. Zhonghuang Li's co-authors include Jiajie Zhang, Shanhe Wan, Yuanxin Tian, Xiaoyun Wu, Guangfa Wang, Zhengguang Zhu, Hong Jin, Tingting Zhang, Junyan Zhang and Ying Jiang and has published in prestigious journals such as International Journal of Molecular Sciences, Molecules and Biochemical Pharmacology.

In The Last Decade

Zhonghuang Li

31 papers receiving 499 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhonghuang Li China 15 288 154 101 67 55 32 508
Zhouling Xie China 16 277 1.0× 158 1.0× 141 1.4× 73 1.1× 49 0.9× 46 643
Hanan S. Anbar Egypt 16 272 0.9× 224 1.5× 105 1.0× 33 0.5× 49 0.9× 45 605
Qianbin Li China 18 467 1.6× 295 1.9× 157 1.6× 135 2.0× 58 1.1× 66 886
Mei Su China 14 212 0.7× 171 1.1× 76 0.8× 29 0.4× 25 0.5× 36 559
Hongbo Xie China 12 223 0.8× 87 0.6× 150 1.5× 37 0.6× 96 1.7× 29 468
Liyan Ji China 15 332 1.2× 101 0.7× 143 1.4× 75 1.1× 11 0.2× 30 644
Jean E. Bemis United States 9 241 0.8× 117 0.8× 94 0.9× 71 1.1× 36 0.7× 9 769
Deeba Shamim Jairajpuri Bahrain 14 294 1.0× 70 0.5× 54 0.5× 28 0.4× 114 2.1× 35 648
Tonika Bohnert United States 9 228 0.8× 94 0.6× 138 1.4× 21 0.3× 77 1.4× 9 558
Solveigh C. Koeberle Germany 10 288 1.0× 81 0.5× 41 0.4× 67 1.0× 51 0.9× 15 484

Countries citing papers authored by Zhonghuang Li

Since Specialization
Citations

This map shows the geographic impact of Zhonghuang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhonghuang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhonghuang Li more than expected).

Fields of papers citing papers by Zhonghuang Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhonghuang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhonghuang Li. The network helps show where Zhonghuang Li may publish in the future.

Co-authorship network of co-authors of Zhonghuang Li

This figure shows the co-authorship network connecting the top 25 collaborators of Zhonghuang Li. A scholar is included among the top collaborators of Zhonghuang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhonghuang Li. Zhonghuang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Xiaotian, Qian Guo, Shanhe Wan, et al.. (2025). Design and synthesis of Betti base derivatives as EGFR inhibitors. Bioorganic Chemistry. 164. 108872–108872.
2.
Wang, Shuyi, Xiaotian Xu, Qian Guo, et al.. (2024). Identification of New EGFR Inhibitors by Structure-Based Virtual Screening and Biological Evaluation. International Journal of Molecular Sciences. 25(3). 1887–1887. 6 indexed citations
3.
Zhao, Zean, Xinhua Chen, Jiajun Luo, et al.. (2024). Design, synthesis and bioactivity evaluation of isobavachin derivatives as hURAT1 inhibitors for hyperuricemia agents. European Journal of Medicinal Chemistry. 277. 116753–116753. 3 indexed citations
4.
5.
Jiang, Ying, Chunhui Huang, Guowu Wu, et al.. (2023). A Novel and Highly Selective Epidermal Growth Factor Receptor Inhibitor, SMUZ106, for the Treatment of Glioblastoma. Pharmaceutics. 15(5). 1501–1501. 5 indexed citations
6.
Luo, Jiajun, Xinhua Chen, Zean Zhao, et al.. (2023). Mechanism of anti-hyperuricemia of isobavachin based on network pharmacology and molecular docking. Computers in Biology and Medicine. 155. 106637–106637. 16 indexed citations
7.
Guo, Qian, Shuyi Wang, Shanhe Wan, et al.. (2022). Design and synthesis of proteolysis targeting chimeras (PROTACs) as an EGFR degrader based on CO-1686. European Journal of Medicinal Chemistry. 238. 114455–114455. 22 indexed citations
8.
Chen, Xinhua, Zean Zhao, Jiajun Luo, et al.. (2021). Novel natural scaffold as hURAT1 inhibitor identified by 3D-shape-based, docking-based virtual screening approach and biological evaluation. Bioorganic Chemistry. 117. 105444–105444. 16 indexed citations
9.
Pan, Xiaoyan, Xi Xie, Qi Chen, et al.. (2020). The seafood Musculus senhousei shows anti-influenza A virus activity by targeting virion envelope lipids. Biochemical Pharmacology. 177. 113982–113982. 15 indexed citations
10.
Jiang, Ying, Zichao Yang, Siming Liu, et al.. (2020). The cytochrome P450 metabolic profiling of SMU-B in vitro, a novel small molecule tyrosine kinase inhibitor. Journal of Pharmaceutical and Biomedical Analysis. 188. 113400–113400. 2 indexed citations
11.
Liu, Siming, Ying Jiang, Zhonghuang Li, et al.. (2019). Design, synthesis and biological evaluations of 2-amino-4-(1-piperidine) pyridine derivatives as novel anti crizotinib-resistant ALK/ROS1 dual inhibitors. European Journal of Medicinal Chemistry. 179. 358–375. 26 indexed citations
12.
Tian, Yuanxin, Shaoyu Wu, Tingting Zhang, et al.. (2018). Understand the acquired resistance of RTK inhibitors by computational receptor tyrosine kinases network. Computational Biology and Chemistry. 76. 275–282. 1 indexed citations
13.
Zhang, Tingting, Yuanxin Tian, Zhonghuang Li, et al.. (2017). Molecular Dynamics Study to Investigate the Dimeric Structure of the Full-Length α-Synuclein in Aqueous Solution. Journal of Chemical Information and Modeling. 57(9). 2281–2293. 15 indexed citations
14.
Tian, Yuanxin, Tingting Zhang, Zhonghuang Li, et al.. (2017). Design, synthesis, biological evaluation and molecular modeling of novel 2-amino-4-(1-phenylethoxy) pyridine derivatives as potential ROS1 inhibitors. European Journal of Medicinal Chemistry. 143. 182–199. 13 indexed citations
15.
16.
Wan, Shanhe, Guangfa Wang, Tingting Zhang, et al.. (2016). Design, synthesis, anti-tumor activity, and molecular modeling of quinazoline and pyrido[2,3-d]pyrimidine derivatives targeting epidermal growth factor receptor. European Journal of Medicinal Chemistry. 118. 276–289. 42 indexed citations
17.
Tian, Yuanxin, Yu‐Dong Shen, Xianzuo Zhang, et al.. (2014). Design Some New Type‐I c‐met Inhibitors Based on Molecular Docking and Topomer CoMFA Research. Molecular Informatics. 33(8). 536–543. 10 indexed citations
18.
Yu, P.Y., Jing‐Rong Li, Zhengguang Zhu, et al.. (2013). Praeruptorin D and E attenuate lipopolysaccharide/hydrochloric acid induced acute lung injury in mice. European Journal of Pharmacology. 710(1-3). 39–48. 32 indexed citations
19.
Ye, Lianbao, Yuanxin Tian, Zhonghuang Li, et al.. (2012). Design, synthesis and molecular docking studies of some novel spiro[indoline-3, 4′-piperidine]-2-ones as potential c-Met inhibitors. European Journal of Medicinal Chemistry. 50. 370–375. 32 indexed citations
20.
Tian, Yuanxin, et al.. (2011). Combined 3D-QSAR and Docking Modelling Study on Indolocarbazole Series Compounds as Tie-2 Inhibitors. International Journal of Molecular Sciences. 12(8). 5080–5097. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhouling Xie Breakdown of academic impact, for papers by Hanan S. Anbar Breakdown of academic impact, for papers by Qianbin Li Breakdown of academic impact, for papers by Mei Su Breakdown of academic impact, for papers by Hongbo Xie Breakdown of academic impact, for papers by Liyan Ji Breakdown of academic impact, for papers by Jean E. Bemis Breakdown of academic impact, for papers by Deeba Shamim Jairajpuri Breakdown of academic impact, for papers by Tonika Bohnert Breakdown of academic impact, for papers by Solveigh C. Koeberle
Rankless by CCL
2026